Welcome to our dedicated page for Concentrix SEC filings (Ticker: CNXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Concentrix's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Concentrix's regulatory disclosures and financial reporting.
OGUT BILGE reported acquisition or exercise transactions in this Form 4 filing.
Concentrix Corp director Bilge Ogut received 7,701 shares of common stock as a restricted stock unit award. The grant was made at no cash cost to the director and represents equity-based compensation rather than an open-market purchase or sale.
According to the terms, these restricted stock units vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders. After this award, Ogut holds 7,701 shares directly, aligning personal ownership with shareholder interests through time-based vesting.
Deason Jennifer reported acquisition or exercise transactions in this Form 4 filing.
Concentrix Corp director Jennifer Deason received an equity award rather than buying shares on the market. She was granted 7,701 shares of common stock in the form of restricted stock units at no cash purchase price, increasing her direct holdings to 17,704 shares.
The restricted stock units were awarded under the 2020 Stock Incentive Plan and will vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders. This is a compensation-related grant, not an open-market transaction.
Hayley Kathryn reported acquisition or exercise transactions in this Form 4 filing.
Concentrix Corp director Hayley Kathryn received an equity award of 7,701 shares of Common Stock as restricted stock units under the 2020 Stock Incentive Plan. The units were granted at no cash cost and will vest in full on the earlier of the one-year anniversary of grant or the company’s 2027 Annual Meeting of Stockholders.
After this award, Kathryn directly holds 17,712.1206 shares. She also has an indirect holding of 3,034.2930 shares held by a trust, giving her both direct and trust-based exposure to Concentrix stock.
Marinello Kathryn V reported acquisition or exercise transactions in this Form 4 filing.
Concentrix Corp director Kathryn V. Marinello received an equity grant of 7,701 shares of common stock as restricted stock units. The award was made at no cash price under the 2020 Stock Incentive Plan and vests in full on the earlier of the one-year anniversary of the grant date or the issuer's 2027 Annual Meeting of Stockholders. Following this grant, she directly holds 17,704 shares of Concentrix common stock.
POLK DENNIS reported acquisition or exercise transactions in this Form 4 filing.
Concentrix Corp director Dennis Polk received an equity award of 7,701 shares of Common Stock in the form of restricted stock units. The grant was made at no cash cost per share and increased his direct holdings to 28,924 shares. These restricted stock units, awarded under the 2020 Stock Incentive Plan, vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders.
VEZINA ANN F reported acquisition or exercise transactions in this Form 4 filing.
Concentrix Corp director Ann F. Vezina received a grant of 7,701 shares of Common Stock in the form of restricted stock units. The award was made at no cash price and increases her direct holdings to 19,648 shares.
The restricted stock units were granted under the 2020 Stock Incentive Plan and will vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders.
Concentrix Corporation reported results of its 2026 annual stockholder meeting. Stockholders approved an amendment to the Concentrix Corporation Amended and Restated 2020 Stock Incentive Plan to increase the number of shares available for issuance thereunder by 3,700,000 shares.
They also elected nine directors for terms expiring at the 2027 annual meeting and ratified Ernst & Young LLP as independent registered public accounting firm for fiscal year 2026. In an advisory vote, stockholders approved the compensation of the company’s named executive officers.
Concentrix Corp director Bilge Ogut has filed an initial Form 3 insider ownership report. This filing establishes Ogut’s status as a reporting insider of the company. The data show no share purchases, sales, option exercises, gifts, or other transactions in this filing.
Concentrix Corp director Cheng Chih-Kai filed an initial Form 3, which is the mandatory statement of beneficial ownership for new insiders. The data provided shows no reportable transactions, exercises, gifts, or restructurings, indicating this filing is purely administrative disclosure rather than a trading event.
Concentrix Corp ownership filing: The Vanguard Group amended its Schedule 13G to report 0 shares beneficially owned, representing 0% of the class. The amendment explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 that caused certain Vanguard subsidiaries or business divisions to report separately.
The filing is administrative and reports no voting or dispositive power over Concentrix common stock as of the amendment.